United States Biotechnology & Medical Research

Progenics Pharmaceuticals Inc (PGNX)

Track

Ticker: PGNX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 9 Sep 2019
Value US$3,215,958.99 | Price 116.34 | Shares 18,938 (-16.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-09-11 2019-09-09 B Purchase
Velan Capital, L.P.
Large shareholder
18,938 -16.0%
116.34
US$3,215,959 		18,938 -16.0% 116.34 US$3,215,959
2019-09-09 2019-09-09 B Purchase
LTE Partners, LLC
Large shareholder
3,453 +10.7%
138.15
US$1,006,984 		3,453 +10.7% 138.15 US$1,006,984
2019-09-09 2019-09-05 B Purchase
LTE Partners, LLC
Large shareholder
98,775 -31.0%
19.71
US$2,904,084 		98,775 -31.0% 19.71 US$2,904,084
2019-09-05 2019-09-04 B Purchase
Velan Capital, L.P.
Large shareholder
243,614 +3.2%
4.51
US$1,098,529 		243,614 +3.2% 4.51 US$1,098,529
2019-09-05 2019-09-03 B Purchase
Velan Capital, L.P.
Large shareholder
277,424 +3.7%
4.39
US$1,218,918 		277,424 +3.7% 4.39 US$1,218,918
2019-08-27 2019-08-26 B Purchase Velan Capital, L.P. Large shareholder
73,230 +1.0%
4.30
US$314,911 		73,230 +1.0% 4.30 US$314,911
2019-08-27 2019-08-23 B Purchase Velan Capital, L.P. Large shareholder
130,826 +1.8%
4.31
US$563,690 		130,826 +1.8% 4.31 US$563,690
2017-02-15 2017-02-15 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
150,000 -2.1%
9.55
US$1,432,500 		150,000 -2.1% 9.55 US$1,432,500
2017-02-15 2017-02-14 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
150,000 -2.1%
9.68
US$1,452,000 		150,000 -2.1% 9.68 US$1,452,000
2017-02-15 2017-02-14 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 -1.4%
9.70
US$970,000 		100,000 -1.4% 9.70 US$970,000
2017-02-15 2017-02-14 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
50,000 -0.7%
9.70
US$485,000 		50,000 -0.7% 9.70 US$485,000
2017-02-15 2017-02-14 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
52,600 -0.7%
9.70
US$510,220 		52,600 -0.7% 9.70 US$510,220
2017-02-15 2017-02-13 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 -1.3%
9.70
US$970,000 		100,000 -1.3% 9.70 US$970,000
2017-02-09 2017-02-09 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
1,300 -0.0%
9.69
US$12,590 		1,300 -0.0% 9.69 US$12,590
2017-02-09 2017-02-09 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 -1.3%
9.66
US$966,000 		100,000 -1.3% 9.66 US$966,000
2017-02-09 2017-02-09 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 -1.3%
9.75
US$975,000 		100,000 -1.3% 9.75 US$975,000
2017-02-09 2017-02-07 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
50,000 -0.6%
9.65
US$482,500 		50,000 -0.6% 9.65 US$482,500
2017-02-09 2017-02-07 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 -1.3%
9.74
US$974,000 		100,000 -1.3% 9.74 US$974,000
2015-06-15 2015-06-11 PlS Planned sale ISRAEL ROBERT J

Executive Vice President, Medi

Officer
2,000 -5.4%
6.83
US$13,660 		2,000 -5.4% 6.83 US$13,660
2015-03-16 2015-03-13 PlS Planned sale ISRAEL ROBERT J

Executive Vice President, Medi

Officer
3,000 -7.9%
7.00
US$21,000 		3,000 -7.9% 7.00 US$21,000
2015-03-13 2015-03-11 PlS Planned sale ISRAEL ROBERT J

Executive Vice President, Medi

Officer
2,000 -5.4%
6.83
US$13,660 		2,000 -5.4% 6.83 US$13,660
2015-03-04 2015-03-03 PlS Planned sale ISRAEL ROBERT J

Executive Vice President, Medi

Officer
5,000 -12.5%
6.49
US$32,450 		5,000 -12.5% 6.49 US$32,450
2015-01-13 2015-01-12 PlS Planned sale ISRAEL ROBERT J

Executive Vice President, Medi

Officer
2,000 -5.4%
7.06
US$14,112 		2,000 -5.4% 7.06 US$14,112
2014-12-12 2014-12-11 PlS Planned sale ISRAEL ROBERT J

Executive Vice President, Medi

Officer
3,000 -7.9%
7.07
US$21,201 		3,000 -7.9% 7.07 US$21,201
2014-11-21 2014-11-21 PlS Planned sale ISRAEL ROBERT J

Executive Vice President, Medi

Officer
9,000 -20.4%
7.00
US$63,000 		9,000 -20.4% 7.00 US$63,000
2014-11-14 2014-11-13 PlS Planned sale ISRAEL ROBERT J

Executive Vice President, Medi

Officer
10,000 -22.2%
6.83
US$68,300 		10,000 -22.2% 6.83 US$68,300
2014-11-12 2014-11-11 PlS Planned sale ISRAEL ROBERT J

Executive Vice President, Medi

Officer
5,000 -12.5%
6.53
US$32,650 		5,000 -12.5% 6.53 US$32,650
2014-07-23 2014-07-21 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
388,659 +4.5%
4.73
US$1,838,357 		388,659 +4.5% 4.73 US$1,838,357
2014-07-23 2014-07-18 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
388,200 +4.7%
4.73
US$1,836,186 		388,200 +4.7% 4.73 US$1,836,186
2014-07-23 2014-07-17 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
436,884 +5.6%
4.48
US$1,957,240 		436,884 +5.6% 4.48 US$1,957,240
2014-07-23 2014-07-16 B Purchase Broadfin Healthcare Master Fund Ltd Large shareholder
411,693 +5.6%
4.48
US$1,844,385 		411,693 +5.6% 4.48 US$1,844,385
2013-07-22 2013-07-18 PlS Planned sale ISRAEL ROBERT J

Senior VP Medical Affairs

Officer
5,000 -12.5%
6.33
US$31,650 		5,000 -12.5% 6.33 US$31,650
2013-03-28 2013-03-27 PP Planned purchase Baker Mark Robert

CEO

Executive Director
100 +0.1%
5.36
US$536 		100 +0.1% 5.36 US$536
2013-03-28 2013-03-27 PP Planned purchase Baker Mark Robert

CEO

Executive Director
50 +0.0%
5.34
US$267 		50 +0.0% 5.34 US$267
2013-02-28 2013-02-27 PP Planned purchase Baker Mark Robert

CEO

Executive Director
227 +0.1%
2.75
US$624 		227 +0.1% 2.75 US$624
2013-02-28 2013-02-27 PP Planned purchase Baker Mark Robert

CEO

Executive Director
535 +0.3%
2.72
US$1,455 		535 +0.3% 2.72 US$1,455
2013-01-23 2013-01-22 PP Planned purchase Baker Mark Robert

CEO

Executive Director
315 +0.2%
2.83
US$891 		315 +0.2% 2.83 US$891
2012-11-30 2012-11-28 PP Planned purchase Baker Mark Robert

CEO

Executive Director
7 +0.0%
2.14
US$15 		7 +0.0% 2.14 US$15
2012-11-30 2012-11-28 PP Planned purchase Baker Mark Robert

CEO

Executive Director
1,000 +0.6%
2.13
US$2,130 		1,000 +0.6% 2.13 US$2,130
2012-11-30 2012-11-28 PP Planned purchase Baker Mark Robert

CEO

Executive Director
100 +0.1%
2.13
US$213 		100 +0.1% 2.13 US$213
2012-11-30 2012-11-28 PP Planned purchase Baker Mark Robert

CEO

Executive Director
100 +0.1%
2.13
US$213 		100 +0.1% 2.13 US$213
2012-11-30 2012-11-28 PP Planned purchase Baker Mark Robert

CEO

Executive Director
100 +0.1%
2.12
US$212 		100 +0.1% 2.12 US$212
2012-11-20 2012-11-19 B Purchase Baker Mark Robert

CEO

Executive Director
11,800 +8.2%
1.96
US$23,104 		11,800 +8.2% 1.96 US$23,104
2012-11-19 2012-11-16 B Purchase Baker Mark Robert

CEO

Executive Director
49,793 +53.2%
1.82
US$90,723 		49,793 +53.2% 1.82 US$90,723
2012-11-16 2012-11-15 B Purchase Baker Mark Robert

CEO

Executive Director
48,833 +108.9%
1.69
US$82,332 		48,833 +108.9% 1.69 US$82,332
2012-07-03 2012-07-02 PlS Planned sale ISRAEL ROBERT J

Senior VP Medical Affairs

Officer
1,000 -2.8%
9.79
US$9,790 		1,000 -2.8% 9.79 US$9,790
2012-06-29 2012-06-27 PP Planned purchase Baker Mark Robert

CEO

Executive Director
100 +0.2%
9.29
US$929 		100 +0.2% 9.29 US$929
2012-06-29 2012-06-27 PP Planned purchase Baker Mark Robert

CEO

Executive Director
179 +0.4%
9.29
US$1,663 		179 +0.4% 9.29 US$1,663
2012-06-29 2012-06-27 PP Planned purchase Baker Mark Robert

CEO

Executive Director
21 +0.1%
9.27
US$195 		21 +0.1% 9.27 US$195
2012-06-04 2012-06-01 PlS Planned sale ISRAEL ROBERT J

Senior VP Medical Affairs

Officer
1,000 -2.5%
8.51
US$8,508 		1,000 -2.5% 8.51 US$8,508
2012-05-03 2012-05-01 PlS Planned sale ISRAEL ROBERT J

Senior VP Medical Affairs

Officer
1,000 -2.5%
10.93
US$10,927 		1,000 -2.5% 10.93 US$10,927
2012-04-27 2012-04-25 PP Planned purchase Baker Mark Robert

CEO

Executive Director
100 +0.2%
9.92
US$992 		100 +0.2% 9.92 US$992
2012-04-27 2012-04-25 PP Planned purchase Baker Mark Robert

CEO

Executive Director
100 +0.2%
9.97
US$997 		100 +0.2% 9.97 US$997
2012-04-27 2012-04-25 PP Planned purchase Baker Mark Robert

CEO

Executive Director
15 +0.0%
10.25
US$154 		15 +0.0% 10.25 US$154
2012-04-03 2012-04-02 PlS Planned sale ISRAEL ROBERT J

Senior VP Medical Affairs

Officer
1,000 -2.5%
9.85
US$9,852 		1,000 -2.5% 9.85 US$9,852
2012-03-29 2012-03-28 PP Planned purchase Baker Mark Robert

CEO

Executive Director
140 +0.3%
10.19
US$1,427 		140 +0.3% 10.19 US$1,427
2012-03-29 2012-03-28 PP Planned purchase Baker Mark Robert

CEO

Executive Director
100 +0.2%
10.00
US$1,000 		100 +0.2% 10.00 US$1,000
2012-03-02 2012-03-01 PlS Planned sale ISRAEL ROBERT J

Senior VP Medical Affairs

Officer
1,000 -2.5%
9.82
US$9,817 		1,000 -2.5% 9.82 US$9,817
2012-02-27 2012-02-23 PlS Planned sale SCHEINBERG DAVID A Non-Executive Director
1,250 -2.6%
10.00
US$12,500 		1,250 -2.6% 10.00 US$12,500
2012-02-23 2012-02-22 PP Planned purchase Baker Mark Robert

CEO

Executive Director
1 +0.0%
9.54
US$10 		1 +0.0% 9.54 US$10
2012-02-23 2012-02-22 PP Planned purchase Baker Mark Robert

CEO

Executive Director
100 +0.3%
9.45
US$945 		100 +0.3% 9.45 US$945
2012-02-23 2012-02-22 PP Planned purchase Baker Mark Robert

CEO

Executive Director
2 +0.0%
9.42
US$19 		2 +0.0% 9.42 US$19
2012-02-23 2012-02-22 PP Planned purchase Baker Mark Robert

CEO

Executive Director
100 +0.3%
9.40
US$940 		100 +0.3% 9.40 US$940
2012-02-03 2012-02-03 S Sale BRINER KURT W Non-Executive Director
33,000 -100.0%
10.22
US$337,227 		33,000 -100.0% 10.22 US$337,227
2012-02-02 2012-02-01 PlS Planned sale ISRAEL ROBERT J

Senior VP Medical Affairs

Officer
1,000 -2.5%
9.48
US$9,478 		1,000 -2.5% 9.48 US$9,478
2012-01-26 2012-01-25 PP Planned purchase Baker Mark Robert

CEO

Executive Director
100 +0.3%
9.56
US$956 		100 +0.3% 9.56 US$956
2012-01-26 2012-01-25 PP Planned purchase Baker Mark Robert

CEO

Executive Director
193 +0.5%
9.55
US$1,843 		193 +0.5% 9.55 US$1,843
2012-01-26 2012-01-25 PP Planned purchase Baker Mark Robert

CEO

Executive Director
4 +0.0%
9.50
US$38 		4 +0.0% 9.50 US$38
2012-01-26 2012-01-25 PP Planned purchase Baker Mark Robert

CEO

Executive Director
3 +0.0%
9.49
US$28 		3 +0.0% 9.49 US$28
2012-01-26 2012-01-25 PP Planned purchase Baker Mark Robert

CEO

Executive Director
1 +0.0%
9.45
US$9 		1 +0.0% 9.45 US$9
2012-01-12 2012-01-11 PP Planned purchase Baker Mark Robert

CEO

Executive Director
200 +0.5%
8.87
US$1,774 		200 +0.5% 8.87 US$1,774
2012-01-12 2012-01-11 PP Planned purchase Baker Mark Robert

CEO

Executive Director
191 +0.5%
8.86
US$1,692 		191 +0.5% 8.86 US$1,692
2012-01-04 2012-01-03 PlS Planned sale ISRAEL ROBERT J

Senior VP Medical Affairs

Officer
1,000 -2.5%
8.78
US$8,780 		1,000 -2.5% 8.78 US$8,780
2011-12-02 2011-12-01 PlS Planned sale ISRAEL ROBERT J

Senior VP Medical Affairs

Officer
1,000 -2.5%
6.66
US$6,660 		1,000 -2.5% 6.66 US$6,660
2011-11-01 2011-11-01 PlS Planned sale ISRAEL ROBERT J

Senior VP Medical Affairs

Officer
1,000 -2.5%
6.33
US$6,330 		1,000 -2.5% 6.33 US$6,330
Explore more

More insider trading research around Progenics Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America